Call for papers - Fertility preservation in testicular cancer

Guest Editors

Mehmet Serkan Özkent, MD, Konya City Hospital, Türkiye
Sarah Vij, MD, Cleveland Clinic Foundation, USA

Submission Status: Open | Submission Deadline: 23 June 2025

BMC Urology is inviting submissions for our Collection on Fertility preservation in testicular cancer. This Collection seeks to gather innovative research on fertility preservation in testicular cancer to address the impact of cancer treatment on reproductive health and improve the quality of life for cancer survivors. We invite submissions that explore the efficacy of fertility preservation options, multidisciplinary approaches to fertility care, and the long-term reproductive outcomes of testicular cancer survivors.

New Content Item This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.

Submit to Collection

Meet the Guest Editors

Back to top

Mehmet Serkan Özkent, MD, Konya City Hospital, Türkiye

Dr Mehmet Serkan Özkent is an Associate Professor of Urology at Konya City Hospital in Türkiye. He has extensive experience in general urology, andrology, endourology, and urologic oncology. Dr Özkent is recognized for his expertise in treating a wide range of urological conditions, including urological cancers and stone diseases. His clinical focus includes minimally invasive procedures and open and laparoscopic surgeries. Dr Özkent has authored over 40 peer-reviewed publications. He is an active European Association of Urology (EAU) member and an editorial board member for BMC Urology.

Sarah Vij, MD, Cleveland Clinic Foundation, USA

Dr Sarah Vij is an Assistant Professor of Urology at the Cleveland Clinic Foundation, specializing in male infertility and andrology. She graduated from Northwestern University Feinberg School of Medicine with a distinction in research in 2011. Dr Vij then completed her residency training in urology at the Glickman Urologic and Kidney Institute at Cleveland Clinic. Following residency, she completed fellowship training in Male infertility and andrology at the Cleveland Clinic. Dr Vij serves as Program Director for Cleveland Clinic Foundation’s Male Infertility and Andrology Fellowship and an Associate Program Director for the Urology Residency. She is the director of the Center for Male Fertility. She has authored over 50 peer-reviewed publications. She is an active member of the American Urological Association (AUA), the Society for the Study of Male Reproduction (SSMR), The Society for Male Reproduction and Urology (SMRU), the Society for Sexual Medicine of North America (SMSNA) and the Society of Women in Urology (SWIU).

About the Collection

BMC Urology is inviting submissions for our Collection on Fertility preservation in testicular cancer. This Collection welcomes research that contributes to advancing knowledge in the field of fertility preservation for individuals diagnosed with testicular cancer, with the aim of improving the quality of care provided to affected individuals and contributing to better health outcomes.

Testicular cancer is one of the most common malignancies in men, and its treatment often involves therapies that can compromise fertility. While advances in cancer treatment have significantly improved survival rates, these treatments can adversely impact fertility.

Fertility preservation strategies in testicular cancer have become an increasingly important area of research, aiming to mitigate the impact of cancer treatment on reproductive health. These strategies encompass a range of approaches, including sperm banking, testicular tissue cryopreservation, and hormonal interventions, with the goal of preserving fertility potential for post-treatment parenthood.

Advancing our collective understanding of fertility preservation strategies for testicular cancer is crucial to improving the quality of life for cancer survivors. Recent advances have highlighted the efficacy of various fertility preservation techniques, leading to improved access and utilization of these options for patients undergoing cancer treatment. Additionally, research has emphasized the importance of multidisciplinary collaboration between urologists, oncologists, and reproductive specialists in providing comprehensive fertility care to cancer patients.

This Collection welcomes research that contributes to our understanding of fertility preservation in testicular cancer, including research related to:

Impact of testicular cancer treatment on fertility.
Fertility preservation options for testicular cancer patients.
Multidisciplinary approaches to fertility care in oncology.
Reproductive outcomes and quality of life in testicular cancer survivors.
Psychological and social aspects faced by patients regarding fertility preservation.
The role of genetic counseling in fertility preservation and family planning.
Disparities in access to fertility preservation service.
Patient and healthcare education about fertility preservation strategies.

This Collection aligns with the United Nations' Sustainable Development Goal (SDG) 3: Good Health and Well-Being.

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select Fertility preservation strategies in testicular cancer from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.